PURPOSE. Endothelin (ET)-1 can produce nerve damage analogous to that in optic neuropathies such as glaucoma. The precise source of endothelin in the posterior segment of the eye remains unclear. The present study was conducted to determine whether the retinal pigment epithelium (RPE), which helps maintain the outer blood-retinal barrier, is a local source for ET-1 and whether the amount of ET-1 secreted by the RPE is be differentially regulated by cholinergics and the cytokine TNF-␣. METHODS. Human retinal pigment epithelial cells were cultured either to a mature state (mRPE) for 4 weeks, with well-defined tight junctions, or to a young state (yRPE) for 4 days, with incompletely formed tight junctions. ET-1-like immunoreactivity was determined by immunocytochemistry, and secreted ET-1 was quantified by radioimmunoassay in both cell types. Cells were stimulated with the cholinergic agonist carbachol or with the cytokine TNF-␣ for specific periods. The expression of muscarinic receptor subtypes M 1 and M 3 and the peripheral membrane protein ZO-1 were analyzed by immunoblot and immunocytochemistry, respectively. Expression of preproendothelin-1 (ppET-1) mRNA after application of different stimuli at specific time points was determined by real-time RT-PCR. Carbachol-mediated elevation in intracellular calcium ([Ca 2ϩ ] i ) was also measured in the presence or absence of a selective muscarinic receptor antagonist. RESULTS. Constitutive synthesis and secretion of ET-1 was greater in mRPE than in yRPE cells. TNF-␣ caused a significant increase in ppET-1 mRNA levels and ET-1 secretion in both phenotypes. The disruption and subsequent breakdown of the tight junction barrier was evident in either phenotype after treatments with TNF-␣. There was a concentration-dependent increase in [Ca 2ϩ ] i in both y-and mRPE cells in response to CCh. CCh at 1 M significantly increased ET-1 secretion, a response observed in yRPE but not in mRPE cells. This effect may be mediated primarily by the M 3 receptor subtype and is phospholipase C (PLC) dependent. CONCLUSIONS. Regulation of ET-1 release in ARPE-19 cells was differentially regulated by TNF-␣ and CCh and was dependent on the age of the culture. RPE may be a source for ET-1 in the retina, and its increased release may become more important during breakdown of the blood-retinal barrier, as seen after TNF-␣ treatment. (Invest Ophthalmol Vis Sci. 2003;44: 4885-4894) DOI:10.1167/iovs.03-0387 E ndothelins (ET) are 21-amino-acid potent vasoactive peptides, processed and secreted locally in the eye, 1-4 with immunoreactive ET-1 and -3 expressed most notably in the iris, choroid, retina, optic nerve head, ciliary body, lens, and corneal endothelium.
E ndothelins (ET) are 21-amino-acid potent vasoactive peptides, processed and secreted locally in the eye, [1] [2] [3] [4] with immunoreactive ET-1 and -3 expressed most notably in the iris, choroid, retina, optic nerve head, ciliary body, lens, and corneal endothelium.
1,3-5 ET-1 is also present in the aqueous and vitreous humors. 6, 7 Within in the retina, the retinal pigment epithelium (RPE), photoreceptor inner segments, inner plexiform layer, retinal ganglion cells, and retinal pericytes have also been shown to be immunoreactive for ET-1 mRNA and mature ET-1 protein. 3,5,8 -10 Our laboratory has demonstrated that nonpigmented ciliary epithelium can serve as a source of ET-1 in the anterior chamber and that cholinergics, TNF-␣, and glucocorticoids may regulate its secretion. 4, 11 The ciliary pigment and nonpigmented epithelium (NPE) together constitute the blood-aqueous barrier in the anterior segment, which is contiguous with the outer blood-retinal barrier formed by the RPE at the ora serrata. The ciliary epithelium, primarily the NPE and the RPE secrete a multitude of growth-factor-like substances and thus act as source cells for peptides within the immuneprivileged environment of the eye. 12, 13 Based on these reports and similarities between the NPE and the RPE in regulating fluid transport and acting as secretory cells within their respective local environments, we hypothesized that RPE can act as a source for ET-1.
Our primary intent was to provide a quantitative description of both the mRNA and protein levels of ET-1 in a cell culture model of human RPE. In addition, we quantitatively analyzed both constitutive and regulated secretory pathways for ET-1 in these cells, which emphasizes the temporal aspects of ET-1 synthesis and secretion in the RPE. The rationale for considering the actions of cholinergics on RPE stems from observations that the uvea, including the choroid, is parasympathetically innervated by varicosities arising postganglionically from the pterygopalatine and ciliary ganglions. 14 The dense plexus of cholinergic innervation at the choriocapillaris just beneath the RPE is thought to act postsynaptically on choroidal smooth muscles as well as the RPE. 15 In addition, both immunofluorescence and binding studies have shown that mammalian and avian RPE express abundant muscarinic receptors throughout development and adult stages, similar to that in the brain. [15] [16] [17] [18] [19] The physiological and pathophysiological implications of endothelins at specific regions in the eye, including the RPE, are not well understood. ET-1 along with ET-3 and nitric oxide (NO) may help regulate optic nerve head, retinal, and choroidal blood flow. 20 -23 Higher levels of ET-1 have been implicated in severe cardiovascular and developmental dysfunctions 24 and more recently in the pathophysiology of glaucoma. 25 Exogenous ET-1 administered at the retrobulbar region of the optic nerve results in a neuropathy in a manner similar to glaucoma, 26 and intravitreally injected ET-1 can significantly alter the rate of membrane-bound organelles associated with fast axonal transport in the optic nerve. 27 Presently, we have established that the retinal pigment epithelium (RPE) can act as a local source for ET-1.
The RPE, like most epithelia, form apical tight junctions and polarize with distinct apical and basolateral domains. 28 The development of the outer blood-retinal barrier is a gradual, multistep process that parallels changes in expression and recruitment of proteins involved in formation of the tight junction complex with concomitant decrease in paracellular permeability, akin to most epithelia, including the RPE. 28 -32 Sorting and secretion of proteins in epithelial cells are critically dependent on cell polarity. 33, 34 We have therefore used two phenotypes of RPE to delineate differences in ET-1 secretion that may be dependent on the polarity and maturity of the epithelium. We report that secretion of ET-1 may be differentially regulated (muscarinic or TNF-␣ mediated stimulation) in a cell culture system of polarized or mature RPE (mRPE) and nonpolarized or young RPE (yRPE) cells.
MATERIAL AND METHODS

Antibodies
The rabbit anti-muscarinic receptor M 1 (epitope corresponding to part of the i3 loop-residues 231-350) and goat anti-M3 subtypes (epitope corresponding to the C-terminal region) were purchased from Santa Cruz Biotechnology, Santa Cruz, CA. Rat heart lysate and the blocking peptide purchased from Santa Cruz were used as controls for M 1 and M 3 receptor detection respectively. Mouse anti-ZO-1 was purchased from Zymed Laboratories (San Francisco, CA). Rabbit anti-endothelin-1 (anti-ET-1) was purchased from Bachem/Peninsula Laboratories (Belmont, CA). The same antibody was used in radioimmunoassay measurements (secreted ET-1) and immunofluorescence experiments (intracellular ET-1). Rabbit IgG and mouse IgG were purchased from Vector Laboratories (Burlingame, CA). Secondary antibodies including donkey anti-rabbit IgG, donkey anti-mouse IgG, and bovine anti-goat IgG conjugated to horseradish peroxidase (HRP) were purchased from Amersham Biosciences (Piscataway, NJ). Fluorescent probes, including goat anti-rabbit Alexa 488 and goat anti-mouse Alexa 594, were purchased from Molecular Probes (Eugene, OR).
Cell Culture
ARPE-19 human retinal pigment epithelial cells, a spontaneously transformed cell line, was purchased from the American Type Culture Collection (ATCC, Manassas, VA). ARPE-19 cells (passages 20 -23) were maintained at 37°C and 5% CO 2 in a 1:1 mixture of Dulbecco's modified Eagle's medium (DMEM) and Ham's F-12 (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT), 2 mM L-glutamine, 23 mM NaHCO 3 , and penicillin and streptomycin (Invitrogen). The spontaneously arising ARPE-19 cells, characterized by Dunn et al., 35 display typical polarized epithelial morphology when grown according to conditions described by them. In addition, mature polarized ARPE-19 cells that are maintained in culture for 3 to 4 weeks have reduced paracellular permeability and higher transepithelial resistance (TER) compared with cultures that are grown for 1 week. 35 We used culture conditions similar to those described by Dunn et al. 35, 36 to obtain mRPE cells. Cellular morphology for both young (3-4 days in culture) and mature phenotypes was similar to those shown by Dunn et al. 35 Cells were seeded at 1. 4 Treatment incubations were for 24 hours in most of the experiments or during a time course (1, 4, 8, 16 , and 24 hours). The extraction protocol for ET-1 was performed as previously described by Prasanna et al. 4 Efficiency of ET-1 recovery was 75% Ϯ 3% (n ϭ 3). Measurement of immunoreactive ET-1 (ir-ET-1) was according to manufacturer's instructions in a commercially available RIA kit for ET-1 (Peninsula Laboratories, Belmont, CA). 4 
Intracellular Ca 2؉ Measurement
Intracellular Ca 2ϩ ([Ca 2ϩ ] i ) in y-and mRPE cells was measured at 37°C by the ratiometric technique using fura-2AM (excitation at 340 nm and 380 nm, emission at 500 nm) according to Prasanna et al.
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Total RNA Extraction, cDNA Synthesis, and Quantitative Reverse Transcriptase-Polymerase Chain Reaction
Total RNA was isolated from y-and mRPE cells, grown in 100-mm dishes to subconfluent or confluent states and treated as described earlier. Extraction reagent (TRIzol; Invitrogen) was used for total RNA isolation, as previously described. 38 Five micrograms of total RNA was used to synthesize the corresponding cDNA, using avian myeloblastosis virus (AMV) reverse transcriptase (Promega, Madison, WI) and random primers (Promega) in a reaction volume of 50 L at 42°C for 30 minutes. Quantitative PCR (QPCR) primers for human preproET-1 (ppET-1; Fisher Scientific-Genosys, Plano, TX) were designed from the respective cDNA sequence, using an automated sequencing program (GeneJockey II; Biosoft, Ferguson, MO). The primer sequences for human ppET-1 were designed so that they spanned different exons. ␤-Actin served as an internal control that accounted for variability in the initial concentration, quality of the total RNA, and conversion efficiency of the reverse transcription reaction. The primer sequences for ppET-1 and ␤-actin were as follows: ppET-1-forward/sense 5Ј-TATCAGCAGTTAGTGAGAGG-3Ј and reverse/antisense 5Ј-CGAAG-GTCTGTCACCAATGTGC-3Ј, with an expected amplicon/product size of 180 bp; ␤-actin-forward/sense 5Ј-TGTGATGGTGGGAATGGGT-CAG-3Ј and reverse/antisense 5Ј-TTTGATGTCACGCACGATTTCC-3Ј with an expected amplicon/product size of 514 bp. QPCR was performed as described by Zhang et al. 11 Product authenticity was confirmed by DNA sequencing followed by a BLAST homology search of the resulting sequences (data not shown). Quantitation of relative ppET-1 transcript levels in ARPE-19 was achieved using the comparative threshold cycle (C T ) method, as described by the manufacturer (User Bulletin #2: ABI Prism 7700 Sequence Detector; http://docs.appliedbiosystems.com/pebiodocs/04303859.pdf).
QPCR data are presented as the mean percentage of the value of its corresponding untreated control in three separate experiments.
Membrane Isolation and Immunoblot Analysis
Membrane preparation and immunoblot analysis were performed according to Zhang et al. 11 Sixty micrograms per lane (for M 1 receptor detection), 100 g/lane (for M 3 receptor detection), or 50 g/lane (for ZO-1 detection) of the membrane protein was boiled with the SDS page sample buffer and loaded onto 7.5% SDS-PAGE gels and run at 80 V for 2 to 3 hours. Gel contents were electrophoretically transferred to 0.45-m pore size polyvinylidene difluoride (PVDF) membrane (Millipore, Bedford, MA) overnight at 30 V and at 4°C. Blots were probed with the desired primary antibody (in 3% nonfat dry milk): rabbit anti-muscarinic M 1 receptor (final concentration, 0.7 g/mL), goat anti-muscarinic M 3 receptor (2 g/mL), or mouse anti-ZO-1 (1.5 g/ mL) for 1 hour. The rat heart lysate was used as a control for the muscarinic M 1 receptor (Santa Cruz Biotechnology) and the M 3 blocking peptide (control antigen; Santa Cruz Biotechnology) for the M 3 receptor detection according to the manufacturer's instructions. After secondary antibody incubation, blots were rinsed and developed using enhanced chemiluminescence (ECL) reagents (Amersham Pharmacia Biotech).
Immunofluorescence Microscopy
yRPE and mRPE cells were grown on 25-mm glass coverslips for the desired period and treated as indicated. Cells were fixed in 4% paraformaldehyde in PBS (15 mM KCl, 468 mM NaCl, 580 mM Na 2 HPO 4 .7H 2 O and 27 mM KH 2 PO 4 ) for 30 minutes at room temperature followed by permeabilization with 0.2% Triton X-100 for 15 minutes. Cells were rinsed in PBS and incubated twice in 50 mM glycine, 15 minutes per incubation. Each coverslip was carefully inverted (cell-side facing solution) onto 200 L of blocking solution containing 3% BSAϩ3% normal goat serum in PBS for 30 minutes. The coverslips were then incubated in rabbit anti-ET-1 (10 g/mL) for 4 hours at 4°C followed by incubation in a mixture containing rabbit anti-ET-1 (10 g/mL) and mouse anti-ZO-1 (10 g/mL), overnight at 4°C. The antibody used for intracellular ET-1 detection was the same antibody as that used in the ET-1 RIA measurements. Coverslips were rinsed and allowed to incubate in a mixture of secondary antibodies containing Alexa 594 -conjugated donkey anti-mouse (5 g/mL) and Alexa 488 -conjugated donkey anti-rabbit (5 g/mL) for 1 hour in the dark at room temperature. Nuclei were stained with DAPI (300 nM; Molecular Probes) for 10 minutes. Coverslips were mounted on glass slides in antifade medium (FluorSave; Calbiochem, La Jolla, CA) and allowed to dry for 20 minutes in the dark. Cells were viewed with a digital fluorescent microscope (Microphot FXA; Nikon, Tokyo, Japan) and images at the red, green, and blue wavelengths were acquired with a CCD-camera and digitally processed using image-analysis software (IPLab; Scanalytics, Billerica, MA). All images were deconvolved with the same software and transferred for further analysis (Photoshop, ver. 7.0; Adobe Systems, Mountain View, CA).
Data Analysis
Quantitative data are represented as the mean Ϯ SEM. Statistical comparisons were performed by t-test in most experiments, except for ET-1 RIA measurements, for which comparisons between control and multiple treatments were made with ANOVA and the Student-Newman-Keuls (SNK) test. In [Ca 2ϩ ] i measurements, comparisons between baseline, peak, and 1-minute postpeak values were made by one-way, repeated-measures ANOVA. Sample size and probabilities for each experiment are indicated in the figure legends.
RESULTS
In the present study we compared two different phenotypes of RPE in cell culture: a mature culture (4 -5 weeks, mRPE), similar to an intact polarized and differentiated epithelium with few intercellular gaps, and a young culture (3-4 days, yRPE) that has an incomplete barrier formed with more intercellular gaps and possible lack of polarization. The two RPE cell phenotypes were tested for their ability to secrete ET-1 after application of a cytokine (TNF-␣) or a cholinergic agonist (CCh).
Secretion and Regulation of ET-1 in ARPE-19 Cells
yRPE and mRPE cells were incubated with either TNF-␣ (10 nM) or CCh (0.01-100 M), a nonselective muscarinic receptor agonist for 24 hours (Fig. 1) . In yRPE cells (Fig. 1A) , TNF-␣ and CCh (1 M) significantly enhanced ir-ET-1 secretion compared with the untreated control. The extent to which TNF-␣ potentiated ir-ET-1 secretion was higher than that produced by CCh 1 M. It was only at the 1-M concentration that CCh was consistently able to stimulate ET-1 release in yRPE. There are five muscarinic receptor subtypes (M 1-5 ), 26, 39 of which M 1 , M 3 , and M 5 are directly coupled to the G q -IP 3 -Ca 2ϩ signaling pathway, whereas the M 2 and M 4 subtypes are coupled to the G i -cAMP cascade. Activation of the IP 3 -Ca 2ϩ cascade requires prior activation of the G-protein-coupled receptor-mediated transducer phospholipase C␤ (PLC␤). 40, 41 To (Fig. 1A) . Selective muscarinic receptor antagonists were then used for further delineation of the receptor subtype(s) that were involved in ET-1 release in yRPE cells. The compounds 4-DAMP, a selective M 1 /M 3 receptor antagonist (pKi: 9.4 and 9.1 for M 1 and M 3 , respectively), and pirenzepine (PZE), an M 1 -selective antagonist (pKi: 6.9 for M 1 ), 42, 43 were used in our study. Both 4-DAMP and PZE were effective in inhibiting CCh-induced ET-1 release with an apparent relative order of potency of 4-DAMP Ͼ PZE (Fig. 1A) . mRPE cells were allowed to grow for 4 weeks to form an intact epithelial barrier (see Fig. 5 ). The basal amounts (untreated controls) of both ppET-1 mRNA (see Fig. 8 ) and secreted ir-ET-1 measured in these cells (mRPE) was higher than yRPE cells after 24 hours (compare scales in Figs. 1A and 1B). TNF-␣ continued to potentiate ET-1 secretion in mRPE cells to the same degree as that observed in yRPE (four to fivefold increase over control). A similar increase in released ET-1 was not observed in mRPE after CCh treatments for 24 hours (Fig. 1B) .
M 1 and M 3 Muscarinic Receptors in ARPE-19
Differences in secretion of ir-ET-1 in m-and yRPE cells in response to CCh and TNF-␣ may be due to differential expression of M 1 and M 3 receptors or differences in the intracellular calcium ([Ca 2ϩ ] i ) trends after muscarinic receptor activation. The primary reason M 1 and M 3 receptor subtypes were considered was that 4-DAMP and PZE were effective in inhibiting CCh-mediated ET-1 release in the yRPE (Fig. 1A) . In addition, CCh mediated phosphoinositide hydrolysis and the subsequent increase in [Ca 2ϩ ] i in human RPE cells may be predominantly M 3 receptor mediated. 16 Because 4-DAMP has a 6-to 13-fold lower affinity for the M 5 receptor compared with that for M 3 or M 1 receptors 42 and the concentrations we used in our studies and previous reports on muscarinic receptor expression in RPE, 15, 44 it was evident that either the M 3 or M 1 or both subtypes were principal targets for CCh-induced ET-1 secretion in yRPE.
Both M 1 and M 3 receptors are expressed in ARPE-19 cells (yand mRPE; Fig. 2 ). The apparent molecular weights of the protein bands (M 1 R: 60 kDa and M 3 R: 70 kDa) were confirmed by using appropriate controls (rat heart lysate for M 1 R and the blocking peptide for M 3 R). Detection of the M 3 receptor subtype in y-and mRPE cells required higher amounts of total protein (100 g/lane for M 3 15 Because the immunoblot analysis indicated there were differences in the expression of M 1 and M 3 receptors between y-and mRPE cells, it was possible that functional differences between the receptors existed as well. Representative [Ca 2ϩ ] i trends in y-and mRPE cells after CCh (1, 10, 100 M) stimulation are shown in Figures 3A and 3B , respectively, and a summary of the results are shown in Tables 1 and 2 . There was a concentration-dependent increase in the mean [Ca 2ϩ ] i mobilized by CCh in both y-and mRPE with characteristic biphasic transients observed in both phenotypes (Fig. 3) . Because 1 ⌴ CCh was effective in evoking significant release of ET-1 in yRPE cells (Fig. 1A) , this concentration was used for all future experiments in these cells. To address the receptor subtypes that were functionally coupled to the CCh response, different concentrations of 4-DAMP (M 1 /M 3 selective inhibitor) and PZE (M 1 selective inhibitor) were used. U73122 (2 ⌴) blocked CChmediated [Ca 2ϩ ] i mobilization (Table 1) , consistent with results observed in which similar treatments effectively blocked CCh-mediated ET-1 secretion in yRPE cells (Fig. 1A) . PZE (100 nM) failed to inhibit CCh-mediated [Ca 2ϩ ] i elevation and re- quired a concentration of 400 nM or more to do so (Table 1) . 4-DAMP unlike PZE, continued to inhibit CCh-mediated [Ca 2ϩ ] i elevation at concentrations similar to those used in Figure 1A .
To determine whether the RIA results were due to functional uncoupling of muscarinic receptors (receptor desensitization and/or internalization) in their ability to mobilize Fixed cells were probed with mouse anti ZO-1 (B-F) and rabbit anti ET-1 (C-K), followed by incubation with donkey anti-mouse Alexa 594 antibody (5 g/mL, red fluorescence) and donkey anti-rabbit Alexa 488 antibody (5 g/mL, green fluorescence). Nuclei were stained with DAPI (300 nM, blue fluorescence), and merged images are shown in (D), (H), and (L). TNF-␣ but not CCh caused visible changes in morphology and disruption of tight junctions (ZO-1 staining). At least five different fields were viewed per coverslip and a total of three coverslips per condition (n ϭ 3) were tested under similar conditions. Negative controls (M-P) using nonimmune IgG at concentrations identical for anti-ZO-1 and anti-ET-1 showed little or no staining. Scale bar, 10 m.
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IOVS 2ϩ ] i , cells were preincubated with CCh (1 and 100 M) for 24 hours followed by CCh (1 and 100 M) challenge (Table 1) . Cells pretreated with CCh 1 M were able to retain approximately 50% of their response to acute CCh 1 M as opposed to CCh 100 M, where the response was reduced to 10% of the initial response without pretreatment. Similar results were observed in mRPE cells (Table 2) in their ability to mobilize [Ca 2ϩ ] i after CCh (1, 10, 100 M) additions before or after pretreatments. A comprehensive study using muscarinic receptor antagonists were not performed in the mRPE cells, because CCh failed to evoke any significant increase in ET-1 release in these cells (Fig. 1B) . However, 4-DAMP (5 and 10 nM) completely inhibited CCh-mediated [Ca 2ϩ ] i elevation in these cells (data not shown), similar to that observed in yRPE cells, suggesting that both phenotypes had similar responses to CCh in their ability to mobilize [Ca 2ϩ ] i .
Disruption of Tight Junctions by TNF-␣ and Its Influence on Intracellular and Secreted ET-1
Several recent studies have proposed that tight junction and sub-tight-junction domains form clusters of scaffolding proteins that could be important in regulating paracellular transport, cell motility, membrane integrity, and recruitment of exocytotic machinery. 47 We hypothesized that the presence of a mature tight junction complex may regulate secretion of ET-1 in mRPE cells. mRPE cells expressed abundant amounts of ZO-1, a peripheral tight junction-associated protein in epithelial cells. Immunoblot and immunofluorescence analysis was used to determine the extent of ZO-1 expression in both phenotypes. There was a significant increase in ZO-1 expression in mRPE as opposed to yRPE cells (50 g/lane, n ϭ 3) with both isoforms of ZO-1 (␣ϩ and ␣Ϫ; data not shown). Immunofluorescence studies demonstrated that the mRPE cells expressed greater amounts of ZO-1 with well-defined tight junctions compared with yRPE cells (Figs. 4, 5) .
TNF-␣ caused visible changes in morphology, an increase in intercellular gaps and disruption of tight junctions in both yand mRPE cells (Figs. 4, 5 ). These changes were not observed after CCh treatment. Intracellular ET-1 was detected as punctate stains in both phenotypes. Although there were differences in the intensities of intracellular ET-1 content between cells on the same coverslip, basal intracellular ET-1 in yRPE was visibly higher than in mRPE cells (compare Figs. 4C and 5C ). Negative controls including nonimmune serum (Fig. 5) and no primary or secondary antibodies (data not shown) confirmed the authenticity of detection.
Time-Dependent Changes in ZO-1 and ET-1 after TNF-␣
To determine whether TNF-␣-mediated changes in mRPE cells were time dependent, we measured the amount of secreted ir-ET-1 (Fig. 6 ), immunofluorescent ZO-1, and intracellular ET-1 (Fig. 7) expression at 1, 4, 8, 16 , and 24 hours after treatment with TNF-␣. Constitutive ppET-1 (preproET-1) mRNA expression in mRPE cells was more than four times that in yRPE cells during 24 hours (Fig. 8) . This finding was in agreement with differences in constitutive secretion of mature ir-ET-1 over the same time period (Figs. 1A, 1B) . ppET-1 mRNA expression was measured in response to TNF-␣ or CCh in y-and mRPE cells at the indicated time points (Fig. 9) . TNF-␣ significantly increased the amount of secreted ET-1 at the end of 8 hours (Fig. 6 ) and continued to do so until 16 and 24 hours, when the highest amounts of secreted ET-1 were measured. In addition, TNF-␣ caused visible alteration in cellular morphology and disruption of tight junctions, an effect that was first detected at 8 hours and persisted until 24 hours (Fig. 7) . ppET-1 mRNA levels in mRPE cells were significantly elevated (ϳ4-fold) at the end of the first hour after TNF-␣ stimulation and gradually decreased to approximately 1.5-fold of control at the end of 24 hours (Fig.  9B ). There was a gradual and significant increase in ET-1 release at 8, 16, and 24 hours after TNF-␣ administration (Fig. 6) . CCh failed to increase ppET-1 transcription in both phenotypes at the end of 24 hours.
DISCUSSION
Several physiological or pathophysiological stimuli can cause the release of ET-1 and are considered to be regulators of the secretion of ET-1. Cytokines, including TGF-␤, 48 IL-1, 49 TNF␣, 4, 50 and interferon (IFN)-␥, 51 can induce both transcription and release of ET-1. ET-1 secretion typically results from activation of the constitutive or regulated pathways. 52, 53 Unlike CCh, TNF-␣ can influence mRNA synthesis and secretion of ET-1, 54 and several studies have reported the ability of TNF-␣ to cause cytoskeletal changes including breakdown of the tight junction barrier in epithelial cells and RPE. [55] [56] [57] TNF-␣ has been shown to decrease the turnover of occludin, one of the integral proteins of the tight junction complex. 58 In yRPE cells, the tight junction complex appears to be premature and the epithelial phenotype to be nonpolarized and undifferentiated. 31, 59 Failure to recruit desired proteins at the tight junction complex and execution of the barrier, fence, and signaling functions 47 may alter both constitutive and regulated release (by CCh and TNF-␣) of ET-1 in RPE cells. Constitutive synthesis and secretion of ET-1 was higher in mature RPE cells than in young RPE cells. However, basal intracellular ET-1 (endogenous ET-1) content appeared to be higher in y-than in mRPE cells. This suggests that the rate of constitutive secretion may be higher in m-than in yRPE cells. Constitutive and regulated secretion may be influenced by several factors including polarization by plasma membrane asymmetry and/or Golgi asymmetry, differential sorting of proteins including membrane receptors, and decreased paracellular permeability. The finding that yRPE (nonpolarized) cells had higher amounts of ET-1 secretion when stimulated with CCh than did mRPE (polarized) cells was consistent with this view. In contrast, TNF-␣ enhanced secretion of ET-1 by four-to fivefold at the end of 24 hours in both phenotypes. This was probably due to TNF-␣'s ability not only to enhance ET-1 secretion but also to increase ppET-1 transcription significantly and disrupt tight junctions in RPE cells, all of which were time dependent in mRPE cells. CCh, on the contrary, although able to regulate ET-1 secretion in yRPE cells, failed to enhance ppET-1 transcription or cause significant alterations in cell shape and membrane integrity. Of interest, CCh mobilized [Ca 2ϩ ] i to a similar degree in both y-and mRPE cells, indicating that the cumulative muscarinic receptor-mediated [Ca 2ϩ ] i trends remained unaltered in either phenotype and that ET-1 release mechanisms may not necessarily be coupled to calcium mobilization alone. This was particularly evident in yRPE where significant ET-1 release only occurred at the 1-M concentration of CCh. The inability of lower (Ͻ1 M) and higher (10 -100 M) concentrations of CCh to elicit similar or greater release of ET-1 may have been due to the inability to mobilize the required [Ca 2ϩ ] i and to activate the ET-1 secretory pathway at lower concentrations and/or due to receptor desensitization and internalization at higher concentrations.
Our results suggest that the CCh-mediated ET-1 release may predominantly involve the M 3 muscarinic receptor subtype. However, we cannot totally exclude the participation of M 1 receptors, because 4-DAMP has similar affinities for M 1 as for M 3 receptors. 42, 43 In addition, PZE at 100 nM inhibited CChmediated ET-1 release in yRPE cells. Concentrations of 400 nM PZE or more were necessary to inhibit 1 M CCh-mediated [Ca 2ϩ ] i increase in yRPE cells, suggesting that most of this increase was M 3 mediated and that CCh-mediated ET-1 release was both M 1 and M 3 dependent. The inability of CCh to increase ET-1 secretion in mRPE may have been due to limited paracellular permeability in mRPE cells in addition to recruitment of the tight junction complex that may affect its actions on M 1 receptors.
In conclusion, these results favor a role for CCh in the regulated release of ET-1 in yRPE cells, whereas the actions of TNF-␣ reflect a generalized disturbance in cell morphology, disruption of tight junctions, and enhanced ppET-1 transcription, so that the increased release of ET-1 after TNF-␣ may occur through de novo synthesis and release of ET-1. Such actions would be reminiscent of an inflammatory response during breakdown of the blood-retinal barrier, as seen in proliferative vitreoretinopathy (PVR) and diabetic retinopathy. 12 Our results suggest that the RPE may be the source for ET-1 at the posterior pole of the eye. The implications for physiological function of ET-1 under normal conditions in the RPE are presently unknown. In diseased conditions, a pathologic increase in ET-1 secretion by barrier-compromised RPE may be important in cell migration and proliferation, as seen in PVR. Locally secreted ET-1 could act to produce vasoconstriction and affect cellular responses that minimize damage to a compromised blood-retinal barrier. In addition, released ET-1 may mediate vascular homeostasis as a mechanism to balance vasodilator influences; however, with excessive secretion, ET-1 may promote prolonged vasoconstriction and induce ischemic episodes in the retina. We are presently working on models that will address the role of ET-1 at the outer blood-retinal barrier.
